SEINE BIO · SCIENCE LIBRARY
Hexarelin
Hexarelin is a synthetic GH secretagogue studied in human physiology in the 1990s.
Research compoundA closer look at the research, the uncertainties and the questions worth asking.
THE FULL READING GUIDE · UPDATED OCTOBER 7, 2026
Inside the science of Hexarelin.
Educational purpose only. Not medical advice. Consult licensed provider. Obtain from authorized compounding pharmacies only.
Compounding is an option only where the particular substance, product, and prescribing pathway are lawful; a pharmacy cannot make every research compound available for patient use. Approved finished medicines may also be obtained from licensed non-compounding pharmacies.
Overview
Hexarelin is an experimental growth hormone secretagogue related to the GHRP family. A strong acute hormone response made it interesting to researchers, but potency on a laboratory marker is not a measure of long-term health benefit. It is different from a finished growth-hormone replacement medicine.
Community Use
Peptidepedia’s GHRP-2 profile discusses hexarelin as a comparator within the secretagogue family. An exact hexarelin protocol from these community sources was not cited here, so no dosing claim is attributed to them. Performance-oriented discussion should remain separate from patient-outcome evidence.
Doses, Durations & Cycles
Informal biohacking protocols and published regimens. Attributed website reports for education, not medical recommendations. Multiple publications document circulation; they do not establish a safe dose or validate a cycle.
| Route / formulation | Dose / reported phases | Frequency | Duration / break | Notes and source |
|---|---|---|---|---|
| Subcutaneous | 100 mcg per administration | 1–2 times daily | 4 weeks Break: 4 weeks | Published informal biohacking claim PeptideProbe |
| Subcutaneous | Introductory example: 100 mcg 1–2 times daily; standard example: 200 mcg twice daily | Example dependent | 6–8 weeks Break: 4–8 weeks | Published informal biohacking claim Peptides Institute |
Sources checked October 7, 2026. Educational listing does not establish prescribing approval or availability through Seine Bio.
No FDA-approved hexarelin wellness schedule is established. An acute experimental exposure cannot define a chronic fitness cycle, and hormone responsiveness does not supply a home dosing plan. The protocol chart remains source context rather than directions, with no preparation, administration, or conversion instructions added.
Research Findings
A 1994 double-blind placebo-controlled study involved 12 healthy men receiving an acute intravenous exposure. It showed a dose-related growth-hormone response. It did not establish improved sleep, recovery, muscle gain, or disease outcomes after repeated wellness use, and it cannot resolve the safety of such use.
U.S. Approval & Access
Hexarelin is not FDA-approved. A specific authorized research or lawful patient-product pathway must be established before discussing availability. Research publication does not authorize retail treatment, and a prescription cannot by itself answer every product-law requirement. No controlled-substance scheduling conclusion is inferred from its unapproved status.
What It Does in the Body
The secretagogue mechanism prompts pituitary hormone release. In the cited acute study, growth hormone peaked around 30 minutes and returned to baseline within about four hours. This describes a laboratory response under experimental conditions, not onset, peak clinical benefit, or duration for a wellness program; those clinical timelines remain unestablished.
Benefits & Reported Experiences
A hormone peak is an intermediate endpoint. It cannot predict a change in strength, fatigue, or body composition without a study measuring that outcome in a relevant population. Online rankings by potency therefore should not be read as rankings of effectiveness or as a promised transformation timeline.
Side Effects & Risks
A study of 12 people with brief exposure cannot reliably detect rare events or establish long-term risk. A clinician should review the full endocrine context and concurrent treatments before considering any hormonal intervention. A strong response is not assurance that the response is beneficial or appropriate for the person.
Delivery Options
Intravenous experimental work does not establish equivalence for another route promoted online. Product preparation and exposure must match before a paper can support a claim. This page omits injection, mixing, and consumer dose instructions and does not endorse research-only material for use in people.
Product Quality & Storage
Confirm the actual compound and final formulation rather than treating every GHRP as interchangeable. Quality records can help identify a material but do not demonstrate a clinical benefit. The lack of a standardized approved wellness product also makes assumptions about stability and route equivalence particularly unreliable. Storage must follow the authorized finished product’s labeling or an approved study protocol; temperatures and beyond-use times cannot be inferred from research-vial guidance.
Combinations & Interactions
Combining hexarelin with growth hormone-releasing hormone analogs or other secretagogues creates a separate exposure. Greater hormone release is not proof of a better outcome or lower risk. The acute paper does not validate a consumer combination cycle, and this article provides none.
Talking With Your Provider
Bring fatigue, recovery problems, or hormone concerns to a clinician as symptoms that need assessment. Discuss established options and the evidence that would justify an intervention. A consultation can explain hexarelin research, but it does not guarantee access to the compound or a performance improvement.
Educational purpose only. Not medical advice. Consult licensed provider. Obtain from authorized compounding pharmacies only.
Compounding is an option only where the particular substance, product, and prescribing pathway are lawful; a pharmacy cannot make every research compound available for patient use. Approved finished medicines may also be obtained from licensed non-compounding pharmacies.
Questions about what you read?
Explore the research library Create a free account
Educational information only. A free account lets you request review of your care goals. This profile does not establish availability, clinical suitability or access to the named compound.
Explore clinically appropriate options with a licensed provider. Inquiry does not guarantee a prescription, research-program acceptance or access to a particular substance.
Questions worth bringing to your appointment.
- Are there alternatives that address my goal?
- If treatment is appropriate, what monitoring and follow-up would I need?
- Could my health history or current medicines change the risks?
Saved discussion topics 0
Save topics you would like to discuss with your healthcare provider. Saving is an expression of interest, not a treatment request or medical recommendation.
Saved only in this browser, on this device—not in a patient account. Other people using this browser may see your list. Clear it when using a shared device. This list is not sent to our team.
Explore your next step with SEINE BIO.
Bring your questions to a wellness consultation. Inclusion in this library does not indicate prescribing or product availability. A consultation does not guarantee a prescription.
Explore consultations Back to Growth-hormone signalingEducational information · U.S. context · October 7, 2026. No ordering, personalized dosing or injection instructions.
Bring your saved topics to your care team.
Members can select up to five favorites and send a message for review. Your saved list stays in this browser until you choose what to submit.
Choose saved topics for review →